Company Background and Industry Context - The company was initially established in the Chinese building materials industry, focusing on the tile sector for over 20 years, and successfully launched the domestic polished tile brand, listing on the Shenzhen Stock Exchange [1] - In recent years, tiles have been increasingly used for decorative purposes, leading to oversupply and a general price decline in the market [1] Strategic Transformation and Resource Integration - Recognizing the high risk of relying on a single business, the company completed the relocation of its Shanghai production line to the Jiangxi factory and integrated resources by the end of 2013 [1] - The company has leased out the original Shanghai factory site, covering 590 acres of land and buildings [2] New Product Development and Market Expansion - The company has developed and gradually promoted negative ion health boards, aiming to achieve large-scale sales as soon as possible [2] Elderly Care Industry and Health Sector Strategy - The company is transitioning into the elderly care and health industry, considering national policies, local government opinions, and costs, with a long-term planning approach [2] - Leveraging its resources in Taiwan and the Shanghai factory site, the company aims to integrate the elderly care and medical support industries across the strait through external mergers and acquisitions [2] - Initially, the company will focus on light-asset, operation-heavy, and short payback period businesses, replicating successful operation models to establish a foundation for entering the elderly care and health industry [2] Investor Relations and Participation - The investor relations activity involved specific research by institutions such as Huachuang Securities, Jianghai Securities, Guolian Securities, Donghai Securities, Shanghai Aisupu Industry, individual shareholders, China International Securities, and Jianxin Fund Management Company [1] - The event took place on March 18, 2015, at the company's office in Shanghai, with participation from the company's board secretary, vice president, and securities affairs representative [1]
悦心健康(002162) - 2015年3月18日投资者关系活动记录表